瑞芬太尼与芬太尼静脉麻醉应用于无痛人流术的临床对比研究

目的探讨瑞芬太尼及芬太尼静脉麻醉对于无痛人流的临床应用价值。方法将在2012年6—8月于本院行无痛人流的90例患者随机分成两组:对照组45例给予芬太尼+丙泊酚静脉麻醉;实验组45例给予瑞芬太尼+丙泊酚静脉麻醉。观察比较两组患者的丙泊酚用量、麻醉诱导时间、苏醒时间、定向力恢复时间、离院时间、缩宫痛分级、不良反应、生命体征变化情况。结果实验组的丙泊酚用量明显少于对照组;诱导时间、苏醒时间、定向力恢复时间、离院时间明显短于对照组;术后缩宫痛明显轻于对照组;总不良反应发生率明显低于对照组;麻醉围术期的生命体征指标水平明显比对照组稳定(P均<0.05)。结论瑞芬太尼静脉麻醉在无痛人流手术中的麻醉效果更显著。

Clinical comparative study of Remifentanil or Fentanil intravenous anesthesia for painless artificial abortion

Objective To investigate the clinical value about Remifentanil or Fentanil intravenous anesthesia for painless artificial abortion. Methods Ninety patients admitted to our hospital from Jun 2012 to August 2012 were randomly divided into two groups.The control group(n=45) was given Fentanil and Propofol intravenous anesthesia,but the treatment group(n=45) was given Remifentanil and Propofol intravenous anesthesia.The dose of Propofol,the time for induction of anesthesia,the recovery time,c,the orientation recovery time,the classification of uterine contraction pain,the incidence of adverse reactions and the changes of vital signs in two groups were observed and compared. Results The total dose of Propofol in the treatment group was significantly less than the control group,the time for induction of anesthesia,the recovery time,the orientation recovery time and the orientation recovery time in the treatment group were significantly shorter than the control group;the classification of uterine contraction pain in the treatment group was significantly less than the control group;the total incidence of adverse reactions in the treatment group was significantly lower than the control group;the vital signs target levels in the treatment group were significantly stable than the control group(all P<0.05). Conclusion The effect of Remifentanil intravenous anesthesia for painless artificial abortion is more pronounced.